Silvio E. Inzucchi

2 ta ish

Yale University

1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

   Bernard Zinman, Christoph Wanner, John M. Lachin +9

   Maqola20156 iqtibos

   ABIABI:AkademIndex/2026.other.282498

2. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

   John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi +35

   Maqola20196 iqtibos

   ABIABI:AkademIndex/2026.other.282514